ANCA-Associated Vasculitis: Novel Biologic Shows Promise for Replacing Steroids

(MedPage Today) -- PHILADELPHIA -- An investigational monoclonal antibody targeting C5a complement, when partially or fully substituted for corticosteroids, appeared to help patients with ANCA-associated vasculitis (AAV) avoid some of the side...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news